CD40L-B-CLL

Developed for: B-cell chronic lymphocytic leukemia
Investigated by: Baylor College of Medicine · Center for Cell and Gene Therapy, Baylor College of Medicine · The Methodist Hospital Research Institute

today NCT00078520 · Ph 1

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT00078520	Jan 2003 → Mar 2010	B-cell chronic lymphocytic leukemia	Baylor College of Medicine	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	CD40L-B-CLL	“IL-2-B-CLL 2 x 10\^7; CD40L-B-CLL 0” NCT00078520 ↗